Benralizumab - AstraZeneca/Kyowa Kirin
At a glance
- Drug Originator BioWa
- Drug Licenced by AstraZeneca
- Drug Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antibronchitics; Monoclonal antibodies; Skin disorder therapies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Apoptosis stimulants
- USA Patent Applicants ASTRAZENECA AB
- USA Patents 22
- BLAs 1
- International Patents 756
Disclaimer